Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-09-16
1998-01-20
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
554221, 436 63, C07C40310, A61K 31225, G01N 3348
Patent
active
057101760
ABSTRACT:
This invention relates to the novel compounds of Formula (I) and pharmaceutical compositions containing same, to methods of treating, preventing or ameliorating cancer and other proliferative diseases in a subject in need of such treatment comprising administering a compound of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof. ##STR1##
REFERENCES:
patent: 3882244 (1975-05-01), Lee
patent: 4054589 (1977-10-01), Bollag et al.
patent: 4105681 (1978-08-01), Bollag et al.
patent: 4215215 (1980-07-01), Bollag et al.
patent: 4677120 (1987-06-01), Parish et al.
patent: 4885311 (1989-12-01), Parish et al.
patent: 4900478 (1990-02-01), Gross
patent: 5158773 (1992-10-01), Gross
The New England Journal of Medicine, Massachusetts Medical Society, Jul. 15, 1993, vol. 329, No. 3, pp. 175-189.
Collins SJ, et al., Int.J. Cancer 25: 213-218 (1980) Month Not Available.
Strickland S., et al., Cell 15: 393-403 (1978) Month Not Available.
Chomienne, et al., Blood 76: 1710-1717 Nov. (1990).
Wright DG., Blood 69: 334-337 Jan. (1987).
Toscani, et al., Oncogene Res. 3: 223-238 (1988) Month Not Available.
Prasad KN., et al., Biochem. Cell. Biol. 68: 1250-1255 (1990) Month Not Available.
Rabizadeh E., et al., FEBS Lett. 328: 225-229 Aug. (1993).
Breitman, et al., Cancer Res. 50: 6268-6273 Oct. (1990).
Warrell RP. Jr., et al., N. Engl. J. Med. 324/20:1385-1399 May (1991).
Adamson PC., et al., Journal of the National Cancer Institute 85/12:993-996 Jun. (1993).
Nudelman Abraham
Rephaeli Ada
Bar-Ilan University
Kupat Holim Health Insurance Institution of the General Federati
Richter Johann
Stockton Laura L.
LandOfFree
Retinoyloxy (substituted) methyl butyrates useful for the treatm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retinoyloxy (substituted) methyl butyrates useful for the treatm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoyloxy (substituted) methyl butyrates useful for the treatm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-725755